Issued Patents All Time
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12202901 | Cannabinoid receptor type 1 (CB1) antibodies, encoding nucleic acid molecules thereof and methods of use thereof | Antara Banerjee, Robert J. Hoey, Kacey Sachen, Nikolai Suslov | 2025-01-21 |
| 11746155 | Cannabinoid receptor type 1 (CB1) binding proteins and uses thereof | Antara Banerjee, Robert J. Hoey, Kacey Sachen, Nikolai Suslov | 2023-09-05 |
| 7226940 | Substituted heterocycles for the treatment of diabetes and other diseases | Magnus Pfahl, Catherine Tachdjian, Hussien Al-Shamma, David Pleynet, Lyle W. Spruce | 2007-06-05 |
| 7153875 | Heterocyclic derivatives for the treatment of cancer and other proliferative diseases | Magnus Pfahl, Catherine Tachdjian, Hussien Al-Shamma, David Pleynet, Lyle W. Spruce +2 more | 2006-12-26 |
| 7071218 | N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases | Magnus Pfahl, Catherine Tachdjian, Lyle W. Spruce, Hussien Al-Shamma, Mohamed Boudjelal +2 more | 2006-07-04 |
| 6974826 | Imidazolidinedione derivatives for the treatment of diabetes and other diseases | Magnus Pfahl, Catherine Tachdjian, Hussien Al-Shamma, David Pleynet, Lyle W. Spruce | 2005-12-13 |
| 6765013 | Thiazolidinedione derivatives for the treatment of diabetes and other diseases | Magnus Pfahl, Catherine Tachdjian, Hussien Al-Shamma, David Pleynet, Lyle W. Spruce | 2004-07-20 |
| 6515003 | Heterocyclic derivatives for the treatment of diabetes and other diseases | Magnus Pfahl, Catherine Tachdjian, Hussien Al-Shamma, David Pleynet, Lyle W. Spruce | 2003-02-04 |